-transparent.png){kind=logo}
The in vitro activity of trospectomycin (U-63366; 6'-n-propyl spectinomycin pentahydrate sulfate) was evaluated against 189 clinical isolates of the Bacteroides fragilis group and 65 Bacteroides species isolates. At less than or equal to 8 micrograms/ml, the activity of trospectomycin compared favorably with those of clindamycin and cefoxitin against B. fragilis, Bacteroides distasonis, and Bacteroides vulgatus, and there was no cross resistance to these three drugs among the strains of the B. fragilis group. All the Bacteroides species were susceptible to trospectomycin. The results of this in vitro study indicate that trospectomycin possesses excellent activity against Bacteroides species.
N V Jacobus, and
F P Tally
December 1987,
Antimicrobial agents and chemotherapy,
N V Jacobus, and
F P Tally
September 1976,
Scottish medical journal,
N V Jacobus, and
F P Tally
October 1981,
Journal of clinical microbiology,
N V Jacobus, and
F P Tally
January 1991,
Infection,
N V Jacobus, and
F P Tally
June 1973,
Journal of clinical pathology,
N V Jacobus, and
F P Tally
November 1978,
Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,
N V Jacobus, and
F P Tally
May 1976,
Antimicrobial agents and chemotherapy,
N V Jacobus, and
F P Tally
October 1996,
The Journal of antimicrobial chemotherapy,
N V Jacobus, and
F P Tally
January 1982,
Annals of clinical and laboratory science,
N V Jacobus, and
F P Tally
January 1980,
Scandinavian journal of infectious diseases. Supplementum,
